Pregled bibliografske jedinice broj: 330132
Toll-like receptors and regulatory T cells in systemic lupus erythematosus
Toll-like receptors and regulatory T cells in systemic lupus erythematosus // Abstract book / Banchereau, Jacques ; Sallusto, Federica ; Coffman, Robert (ur.).
Silverthorne (CO), 2007. (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 330132 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Toll-like receptors and regulatory T cells in systemic lupus erythematosus
Autori
Cepika, Alma-Martina ; Marinić, Igor ; Soldo-Jureša, Dragica ; Morović-Vergles, Jadranka ; Gagro, Alenka
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstract book
/ Banchereau, Jacques ; Sallusto, Federica ; Coffman, Robert - Silverthorne (CO), 2007
Skup
Keystone Conference „ Immunological Intervention in Human Disease“
Mjesto i datum
Big Sky (MT), Sjedinjene Američke Države, 06.01.2007. - 11.01.2007
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
autoimmune disease; SLE; patients; therapy; TLR9
Sažetak
Infections have been known to trigger and/or aggravate certain autoimmune diseases, including systemic lupus erythematosus (SLE). Invading microorganisms are recognized by the innate immune system via Toll-like receptors (TLRs). We investigated the TLR expression in peripheral blood cells of SLE patients and healthy controls by multi-color flow cytometry staining. Patients were analyzed before the onset of therapy, after 3 weeks of corticosteroid therapy, and again after 3 months, when chloroquine was added to the protocol. Furthermore, as TLR activation can affect the function of regulatory T cells (Tregs), we performed a 2-year follow-up of a newly diagnosed patient to examine the frequency of Foxp3+ Tregs before and during therapy. Patients taking corticosteroids had lower TLR2 expression on monocytes compared to healthy controls. TLR9 expression in B cells was higher in patients treated with corticosteroids than in controls. When chloroquine was introduced and steroid dose lowered, TLR9 expression fell back to the levels observed in controls. The results of in vitro stimulation of isolated cells from healthy donors with dexamethasone and/or chloroquine were in accordance with TLR expression behavior in patients. The percentage of Foxp3+ Tregs increased after 3 weeks of corticosteroid therapy and remained nearly at the same level after 2 years, although the patient’ s symptoms slightly deteriorated. Further experiments are under way to clarify the significance of TLR and Treg levels in SLE and possible immunomodulatory effects of drugs used in treatment.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
Napomena
Dr. med. Alma-Martina Cepika nagrađena je putnom stipendijom DANA Foundation.
POVEZANOST RADA
Projekti:
072-1080229-0337 - Modulacija funkcije ljudskih regulacijskih T-limfocita (Gagro, Alenka, MZOS ) ( CroRIS)
Ustanove:
Imunološki zavod d.d.,
Klinička bolnica "Dubrava"
Profili:
Igor Marinić
(autor)
Alma-Martina Cepika
(autor)
Dragica Soldo-Jureša
(autor)
Alenka Gagro
(autor)
Jadranka Morović-Vergles
(autor)